FRANKFURT, Dec 9 (Reuters) - Pfizer (PFE.N: Quote, Profile, Research, Stock Buzz) and Eli Lilly (LLY.N: Quote, Profile, Research, Stock Buzz) have submitted offers to buy marketing rights for MediGene's (MDGGn.DE: Quote, Profile, Research, Stock Buzz) EndoTag as the contest over the promising pancreatic cancer drug heats up, two people close to the situation said.
Tuesday, December 09, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment